Erik Sims

Erik Sims serves as the Controller of Ocuphire. He has over 8 years of progressive finance and accounting experience, including public company. Most recently, he spent time in the insurance industry working as the Corporate Controller and member of the management team for a Michigan based firm. He has previously spent time in the life sciences industry, serving as the Assistant Controller for Gemphire Therapeutics from the time they went public in late 2016 until their subsequent merger with NeurBo Pharmaceuticals. In addition, Erik has worked in the software start-up industry for an Ann Arbor based company that was later sold to the digital arm of Deloitte. In his career, he has gained broad experience that will help ensure the integrity and accuracy of the financial statements, along with enhancing processes and procedures for the organization. Erik earned his M.B.A. from Walsh College and a B.B.A. with a Finance concentration from University of Michigan-Flint, School of Management.